BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15097253)

  • 1. Risk factors for elevated intraocular pressure in uveitis.
    Herbert HM; Viswanathan A; Jackson H; Lightman SL
    J Glaucoma; 2004 Apr; 13(2):96-9. PubMed ID: 15097253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
    Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, management and outcome of raised intraocular pressure in childhood-onset uveitis at a tertiary referral centre.
    Tan SZ; Yau K; Steeples LR; Ashworth J; Fenerty C; Jones N
    Br J Ophthalmol; 2019 Jun; 103(6):748-752. PubMed ID: 30021815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study.
    Westfall AC; Lauer AK; Suhler EB; Rosenbaum JT
    J Glaucoma; 2005 Feb; 14(1):3-10. PubMed ID: 15650597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids.
    Shrestha S; Thapa M; Shah DN
    Ocul Immunol Inflamm; 2014 Apr; 22(2):110-5. PubMed ID: 24131295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pathogenesis of Raised Intraocular Pressure in Uveitis.
    Baneke AJ; Lim KS; Stanford M
    Curr Eye Res; 2016; 41(2):137-49. PubMed ID: 25974243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical evaluation of uveitis-associated secondary glaucoma.
    Takahashi T; Ohtani S; Miyata K; Miyata N; Shirato S; Mochizuki M
    Jpn J Ophthalmol; 2002; 46(5):556-62. PubMed ID: 12457916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema?
    Chang JH; McCluskey P; Missotten T; Ferrante P; Jalaludin B; Lightman S
    Br J Ophthalmol; 2008 Jul; 92(7):916-21. PubMed ID: 18460537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Secondary Glaucoma in Herpetic Anterior Uveitis.
    Hoeksema L; Jansonius NM; Los LI
    Am J Ophthalmol; 2017 Sep; 181():55-60. PubMed ID: 28666730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease.
    Yang P; Wang C; Su G; Pan S; Qin Y; Zhang J; Cao Q; Zhong Z; Zhou C; Wang Y; Kijlstra A
    Br J Ophthalmol; 2021 Dec; 105(12):1678-1682. PubMed ID: 33011689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma in Juvenile Idiopathic Arthritis-associated Uveitis.
    Stroh IG; Moradi A; Burkholder BM; Hornbeak DM; Leung TG; Thorne JE
    Ocul Immunol Inflamm; 2017 Aug; 25(4):503-512. PubMed ID: 27003850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.
    Kothari S; Foster CS; Pistilli M; Liesegang TL; Daniel E; Sen HN; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Lawrence SD; Kempen JH;
    Ophthalmology; 2015 Oct; 122(10):1987-2001. PubMed ID: 26233626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular hypertension and secondary glaucoma in children with uveitis.
    Sijssens KM; Rothova A; Berendschot TT; de Boer JH
    Ophthalmology; 2006 May; 113(5):853-9.e2. PubMed ID: 16650683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma in patients with uveitis.
    Panek WC; Holland GN; Lee DA; Christensen RE
    Br J Ophthalmol; 1990 Apr; 74(4):223-7. PubMed ID: 2337547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Intraocular Pressure Elevation and Glaucoma after Lamellar versus Full-Thickness Penetrating Keratoplasty.
    Borderie VM; Loriaut P; Bouheraoua N; Nordmann JP
    Ophthalmology; 2016 Jul; 123(7):1428-34. PubMed ID: 27126929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profile of uveitis-related ocular hypertension.
    Mahajan D; Sharma R; Garg SP; Venkatesh P; Sihota R; Dada T
    Int Ophthalmol; 2014 Dec; 34(6):1221-6. PubMed ID: 25301079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intraocular pressure elevation after descemet stripping automated endothelial keratoplasty.
    Allen MB; Lieu P; Mootha VV; Bowman RW; Petroll WM; Tong L; Kooner KS; Cavanagh HD; Whitson JT; Aggarwal NK
    Eye Contact Lens; 2010 Jul; 36(4):223-7. PubMed ID: 20539235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canaloplasty in patients with uveitic glaucoma: a pilot study.
    Lommatzsch C; Heinz C; Heiligenhaus A; Koch JM
    Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1325-30. PubMed ID: 27052842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of glaucoma in patients with uveitis.
    Neri P; Azuara-Blanco A; Forrester JV
    J Glaucoma; 2004 Dec; 13(6):461-5. PubMed ID: 15534470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.